Douglas Pharmaceuticals Limited - Supply Chain Council
Douglas Pharmaceuticals Limited - Supply Chain Council
Douglas Pharmaceuticals Limited - Supply Chain Council
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
What Accelerated Our Interest In <strong>Supply</strong> <strong>Chain</strong> Improvement<br />
Mid 2007 We Experienced A Burning Platform<br />
• Customer DIFOT (Export) Down to 20%<br />
• Product Lead Times Up to 8 months<br />
• New Product Introduction Lead Times Up to 9 months<br />
• Stock Turns Down to 2.1x<br />
• YTD Sales Down 30%<br />
• Available Spare Capacity Unknown<br />
• Customer complaints impact new licensing opportunities and future<br />
earnings growth<br />
• Converted to new ERP in August 2006<br />
• Potential t impact on 2007/8 earnings and shareholder value goals<br />
– EBIT ‐ Earnings Before Interest and Taxes (15.9%)<br />
– Enterprise Value ($25.2M)<br />
© 2011 <strong>Supply</strong> <strong>Chain</strong> <strong>Council</strong>. ALL RIGHTS RESERVED. | 2011 Global Users Meeting | 6 | 7 February 2011 Rod de Spong & Ravi Seethamraju ANZ Leadership team
Change language